1-9 of 9
Axel Benner
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Circulating miRNAs as Surrogate Markers for Circulating Tumor Cells and Prognostic Markers in Metastatic Breast Cancer

Dharanija Madhavan, Manuela Zucknick, Markus Wallwiener, Katarina Cuk, Caroline Modugno, Martina Scharpff, Sarah Schott, Jörg Heil, Andrey Turchinovich, Rongxi Yang, Axel Benner, Sabine Riethdorf, Andreas Trumpp, Christof Sohn, Klaus Pantel, Andreas Schneeweiss, Barbara Burwinkel
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (21): 5972–5982.
https://doi.org/10.1158/1078-0432.CCR-12-1407
Published: 06 November 2012
View articletitled, Circulating miRNAs as Surrogate Markers for Circulating Tumor Cells and Prognostic Markers in Metastatic Breast Cancer
Open the PDF for Circulating miRNAs as Surrogate Markers for Circulating Tumor Cells and Prognostic Markers in Metastatic Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Overexpression of ZEB2 at the Invasion Front of Colorectal Cancer Is an Independent Prognostic Marker and Regulates Tumor Invasion In Vitro

Christoph Kahlert, Saleh Lahes, Praveen Radhakrishnan, Shamik Dutta, Carolin Mogler, Esther Herpel, Karsten Brand, Gunnar Steinert, Martin Schneider, Martin Mollenhauer, Christoph Reissfelder, Fee Klupp, Johannes Fritzmann, Christina Wunder, Axel Benner, Matthias Kloor, Cathrin Huth, Pietro Contin, Alexis Ulrich, Moritz Koch, Jürgen Weitz
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (24): 7654–7663.
https://doi.org/10.1158/1078-0432.CCR-10-2816
Published: 18 December 2011
View articletitled, Overexpression of ZEB2 at the Invasion Front of Colorectal Cancer Is an Independent Prognostic Marker and Regulates Tumor Invasion In Vitro
Open the PDF for Overexpression of ZEB2 at the Invasion Front of Colorectal Cancer Is an Independent Prognostic Marker and Regulates Tumor Invasion In Vitro in another window
Includes: Supplementary data
Journal Articles

Dynamic Contrast-Enhanced Magnetic Resonance Imaging Identifies a Subgroup of Patients with Asymptomatic Monoclonal Plasma Cell Disease and Pathologic Microcirculation

Jens Hillengass, Christian Zechmann, Tobias Bäuerle, Barbara Wagner-Gund, Christiane Heiss, Axel Benner, Anthony Ho, Kai Neben, Dirk Hose, Hans-Ulrich Kauczor, Hartmut Goldschmidt, Stefan Delorme, Thomas Moehler
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (9): 3118–3125.
https://doi.org/10.1158/1078-0432.CCR-08-2310
Published: 30 April 2009
View articletitled, Dynamic Contrast-Enhanced Magnetic Resonance Imaging Identifies a Subgroup of Patients with Asymptomatic Monoclonal Plasma Cell Disease and Pathologic Microcirculation
Open the PDF for Dynamic Contrast-Enhanced Magnetic Resonance Imaging Identifies a Subgroup of Patients with Asymptomatic Monoclonal Plasma Cell Disease and Pathologic Microcirculation in another window
Journal Articles

High Skp2 Expression Characterizes High-Risk Neuroblastomas Independent of MYCN Status

Frank Westermann, Kai-Oliver Henrich, Jun S. Wei, Werner Lutz, Matthias Fischer, Rainer König, Ruprecht Wiedemeyer, Volker Ehemann, Benedikt Brors, Karen Ernestus, Ivo Leuschner, Axel Benner, Javed Khan, Manfred Schwab
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (16): 4695–4703.
https://doi.org/10.1158/1078-0432.CCR-06-2818
Published: 15 August 2007
View articletitled, High Skp2 Expression Characterizes High-Risk Neuroblastomas Independent of MYCN Status
Open the PDF for High Skp2 Expression Characterizes High-Risk Neuroblastomas Independent of MYCN Status in another window
Includes: Supplementary data
Journal Articles

Lumbar Bone Marrow Microcirculation Measurements from Dynamic Contrast-Enhanced Magnetic Resonance Imaging Is a Predictor of Event-Free Survival in Progressive Multiple Myeloma

Jens Hillengass, Klaus Wasser, Stefan Delorme, Fabian Kiessling, Christian Zechmann, Axel Benner, Hans-Ulrich Kauczor, Anthony D. Ho, Hartmut Goldschmidt, Thomas M. Moehler
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (2): 475–481.
https://doi.org/10.1158/1078-0432.CCR-06-0061
Published: 25 January 2007
View articletitled, Lumbar Bone Marrow Microcirculation Measurements from Dynamic Contrast-Enhanced Magnetic Resonance Imaging Is a Predictor of Event-Free Survival in Progressive Multiple Myeloma
Open the PDF for Lumbar Bone Marrow Microcirculation Measurements from Dynamic Contrast-Enhanced Magnetic Resonance Imaging Is a Predictor of Event-Free Survival in Progressive Multiple Myeloma in another window
Journal Articles

Identification of Gains on 1q and Epidermal Growth Factor Receptor Overexpression as Independent Prognostic Markers in Intracranial Ependymoma

Frank Mendrzyk, Andrey Korshunov, Axel Benner, Grischa Toedt, Stefan Pfister, Bernhard Radlwimmer, Peter Lichter
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (7): 2070–2079.
https://doi.org/10.1158/1078-0432.CCR-05-2363
Published: 11 April 2006
View articletitled, Identification of Gains on 1q and Epidermal Growth Factor Receptor Overexpression as Independent Prognostic Markers in Intracranial Ependymoma
Open the PDF for Identification of Gains on 1q and Epidermal Growth Factor Receptor Overexpression as Independent Prognostic Markers in Intracranial Ependymoma in another window
Journal Articles

Reduced Expression of CAMTA1 Correlates with Adverse Outcome in Neuroblastoma Patients

Kai-Oliver Henrich, Matthias Fischer, Daniel Mertens, Axel Benner, Ruprecht Wiedemeyer, Benedikt Brors, André Oberthuer, Frank Berthold, Jun Stephen Wei, Javed Khan, Manfred Schwab, Frank Westermann
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (1): 131–138.
https://doi.org/10.1158/1078-0432.CCR-05-1431
Published: 05 January 2006
View articletitled, Reduced Expression of CAMTA1 Correlates with Adverse Outcome in Neuroblastoma Patients
Open the PDF for Reduced Expression of CAMTA1 Correlates with Adverse Outcome in Neuroblastoma Patients in another window
Journal Articles

Dose-dependent Effect of Thalidomide on Overall Survival in Relapsed Multiple Myeloma

Kai Neben, Thomas Moehler, Axel Benner, Alwin Kraemer, Gerlinde Egerer, Anthony D. Ho, Hartmut Goldschmidt
Journal: Clinical Cancer Research
Clin Cancer Res (2002) 8 (11): 3377–3382.
Published: 01 November 2002
View articletitled, Dose-dependent Effect of Thalidomide on Overall Survival in Relapsed Multiple Myeloma
Open the PDF for Dose-dependent Effect of Thalidomide on Overall Survival in Relapsed Multiple Myeloma in another window
Journal Articles

High Plasma Basic Fibroblast Growth Factor Concentration Is Associated with Response to Thalidomide in Progressive Multiple Myeloma

Kai Neben, Thomas Moehler, Gerlinde Egerer, Alwin Kraemer, Jens Hillengass, Axel Benner, Anthony D. Ho, Hartmut Goldschmidt
Journal: Clinical Cancer Research
Clin Cancer Res (2001) 7 (9): 2675–2681.
Published: 01 September 2001
View articletitled, High Plasma Basic Fibroblast Growth Factor Concentration Is Associated with Response to Thalidomide in Progressive Multiple Myeloma
Open the PDF for High Plasma Basic Fibroblast Growth Factor Concentration Is Associated with Response to Thalidomide in Progressive Multiple Myeloma in another window